Braster S.A. Cash Flow Conversion Efficiency

Latest as of March 2024: -0.048x

Braster S.A. cash flow conversion efficiency. Based on the latest financial reports, Braster S.A. (BRA) has a cash flow conversion efficiency ratio of -0.048x as of March 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł244.00K ≈ $67.15K USD) by net assets (zł-5.04 Million ≈ $-1.39 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Braster S.A. (2011–2023)

Cash flow conversion efficiency of Braster S.A. from 2011 to 2023. This chart illustrates how Braster S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View BRA live share price for real-time trading data and today's change.

Braster S.A. Cash Flow Conversion Ratio Explained

Braster S.A. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Braster S.A. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Braster S.A. ranked by their cash flow conversion efficiency. Also see BRA market cap for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
TaoWeave Inc.
NASDAQ:TWAV
-0.098x
Erika Carmel Ltd
TA:BCUR
0.113x
Ravi Kumar Distilleries Limited
NSE:RKDL
0.122x
Genesis Resources Ltd
AU:GES
-0.764x
MAST ENERGY DEV. LS -001
F:97D
N/A
Citatah Tbk
JK:CTTH
-0.063x
Asia Pacific Fibers Tbk
JK:POLY
-0.005x
Senti Biosciences Inc
NASDAQ:SNTI
-1.163x

Annual Cash Flow Conversion Efficiency for Braster S.A. (2011–2023)

The table below shows the annual cash flow conversion efficiency of Braster S.A. from 2011 to 2023. Review how much free cash does Braster S.A. generate to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2023-12-31 zł-4.43 Million
≈ $-1.22 Million
zł1.24 Million
≈ $340.17K
-0.279x -114.68%
2022-12-31 zł650.00K
≈ $178.89K
zł1.24 Million
≈ $340.17K
1.902x +298.59%
2021-12-31 zł1.76 Million
≈ $485.75K
zł-1.69 Million
≈ $-465.11K
-0.958x -85.29%
2020-12-31 zł7.90 Million
≈ $2.18 Million
zł-4.08 Million
≈ $-1.12 Million
-0.517x +44.24%
2019-12-31 zł20.79 Million
≈ $5.72 Million
zł-19.27 Million
≈ $-5.30 Million
-0.927x -55.58%
2018-12-31 zł29.02 Million
≈ $7.99 Million
zł-17.28 Million
≈ $-4.76 Million
-0.596x -0.48%
2017-12-31 zł48.80 Million
≈ $13.43 Million
zł-28.93 Million
≈ $-7.96 Million
-0.593x -113.65%
2016-12-31 zł34.84 Million
≈ $9.59 Million
zł-9.67 Million
≈ $-2.66 Million
-0.277x -74.47%
2015-12-31 zł42.00 Million
≈ $11.56 Million
zł-6.68 Million
≈ $-1.84 Million
-0.159x -100.80%
2014-12-31 zł8.81 Million
≈ $2.43 Million
zł-698.00K
≈ $-192.10K
-0.079x +83.70%
2013-12-31 zł5.92 Million
≈ $1.63 Million
zł-2.88 Million
≈ $-791.61K
-0.486x -102.29%
2012-12-31 zł8.64 Million
≈ $2.38 Million
zł-2.07 Million
≈ $-570.99K
-0.240x +96.62%
2011-12-31 zł63.73K
≈ $17.54K
zł-452.66K
≈ $-124.58K
-7.103x --

About Braster S.A.

WAR:BRA Poland Medical Devices
Market Cap
$4.69 Million
zł17.04 Million PLN
Market Cap Rank
#28645 Global
#328 in Poland
Share Price
zł0.58
Change (1 day)
+0.00%
52-Week Range
zł0.58 - zł0.58
All Time High
zł28.50
About

Braster S.A. provides in-home breast cancer examination device worldwide. The company offers Braster System, a device that allows every woman to perform breast examination independently at home; and Braster Pro, a certified medical device that supports the process of breast examination in clinical conditions. It also provides automatic interpretation of results of thermographic breast examination… Read more